Literature DB >> 12112206

Further extension of the H1 haplotype associated with progressive supranuclear palsy.

Pau Pastor1, Mario Ezquerra, Eduardo Tolosa, Esteban Muñoz, María José Martí, Francesc Valldeoriola, José Luís Molinuevo, Matilde Calopa, Rafael Oliva.   

Abstract

The recent finding of disequilibrium among several polymorphisms along the tau gene and the strong association of one of the two haplotypes formed by these polymorphisms (H1) with progressive supranuclear palsy (PSP) suggests that a single allele in or near the tau gene at 17q21 is responsible for increased risk in most of the PSP cases. We sought to determine whether mutations in the tau gene are responsible for the disease in 45 sporadic PSP patients. Furthermore, we analyzed some markers located in the common region of linkage (D17S800-D17S791), associated with some cases of familial frontotemporal dementia (FTDP-17), and the SNPs rs1816 and rs937 close to the tau gene, to determine their possible association with sporadic PSP. We did not find pathogenic mutations in exons 9, 10, 12, or 13 of the tau gene, indicating that tau mutations in both the splice-site region of the exon 10 and in the microtubule-binding region of tau gene are not a cause of PSP in this study group. We found significant overrepresentation of the haplotypes H1, extended up to the promoter of the tau gene (H1P), in PSP patients as compared with controls. In addition, a significant overrepresentation of the D17S810 2/2 and 3/2 genotypes, of the SNP rs1816 A/A, and of the SNP rs937 delG/delG genotypes was detected in PSP, further extending the haplotype described previously. These results are consistent with the hypothesis that a change either in the 5' or in the 3' flanking regions of the tau gene, or even other genes contained in the H1E haplotype, could increase the genetic susceptibility to PSP. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112206     DOI: 10.1002/mds.10076

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

Review 1.  Neurogenetics: single gene disorders.

Authors:  S-M Pulst
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

2.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

3.  The distribution and most recent common ancestor of the 17q21 inversion in humans.

Authors:  Michael P Donnelly; Peristera Paschou; Elena Grigorenko; David Gurwitz; Syed Qasim Mehdi; Sylvester L B Kajuna; Csaba Barta; Selemani Kungulilo; N J Karoma; Ru-Band Lu; Olga V Zhukova; Jong-Jin Kim; David Comas; Marcello Siniscalco; Maria New; Peining Li; Hui Li; Vangelis G Manolopoulos; William C Speed; Haseena Rajeevan; Andrew J Pakstis; Judith R Kidd; Kenneth K Kidd
Journal:  Am J Hum Genet       Date:  2010-01-28       Impact factor: 11.025

4.  H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers.

Authors:  Elisa Canu; Marina Boccardi; Roberta Ghidoni; Luisa Benussi; Cristina Testa; Michela Pievani; Matteo Bonetti; Giuliano Binetti; Giovanni B Frisoni
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

5.  Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

Authors:  Lisa Skipper; Kristen Wilkes; Mathias Toft; Matthew Baker; Sarah Lincoln; Mary Hulihan; Owen A Ross; Mike Hutton; Jan Aasly; Matthew Farrer
Journal:  Am J Hum Genet       Date:  2004-08-03       Impact factor: 11.025

6.  Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype.

Authors:  Sofia A Oliveira; William K Scott; Fengyu Zhang; Jeffrey M Stajich; Kenichiro Fujiwara; Michael Hauser; Burton L Scott; Margaret A Pericak-Vance; Jeffery M Vance; Eden R Martin
Journal:  Neurogenetics       Date:  2004-06-08       Impact factor: 2.660

Review 7.  Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.

Authors:  Tara M Caffrey; Richard Wade-Martins
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

8.  Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Authors:  Nikolaos Refenes; Juliane Bolbrinker; Georgios Tagaris; Antonio Orlacchio; Nikolaos Drakoulis; Reinhold Kreutz
Journal:  BMC Neurol       Date:  2009-06-28       Impact factor: 2.474

9.  Tau gene and Parkinson's disease: a case-control study and meta-analysis.

Authors:  D G Healy; P M Abou-Sleiman; A J Lees; J P Casas; N Quinn; K Bhatia; A D Hingorani; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

10.  Identifying the genetic components underlying the pathophysiology of movement disorders.

Authors:  Mario Ezquerra; Yaroslau Compta; Maria J Marti
Journal:  Appl Clin Genet       Date:  2011-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.